
590 kr
Tax included.
Shipping calculated at checkout.
For Laboratory Research Use Only
Not intended for human or veterinary use.
CJC-1295 No DAC, also known as Modified GRF 1–29, is a synthetic growth hormone-releasing hormone (GHRH) analogue supplied for laboratory research use only.
Published scientific literature has investigated modified GHRH(1–29) analogues in relation to GHRH receptor biology, peptide stability and endocrine signaling research models.
Product Name: CJC-1295 No DAC
Product Type: Synthetic Modified GHRH(1–29) Analogue
Amount: 5 mg / 10 mg
Form: Lyophilized Powder
Purity: ≥99%
Storage: 2–8°C
Batch Testing: Batch-Specific COA Available
Intended Use: Research Use Only
Each batch is linked to a batch-specific Certificate of Analysis (COA).
Available documentation may include purity testing, identity verification, and batch-related analytical data.
Frohman LA, Downs TR, Williams TC, Heimer EP, Pan YC, Felix AM.
Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus.
Journal of Clinical Investigation. 1986;78(4):906–913.
PMID: 3093533 ![]()
DOI: 10.1172/JCI112679 ![]()
Lance VA, Murphy WA, Sueiras-Diaz J, Coy DH.
Super-active analogs of growth hormone-releasing factor (1–29)-amide.
Biochemical and Biophysical Research Communications. 1984;119(1):265–272.
PMID: 6231028 ![]()
DOI: 10.1016/0006-291X(84)91647-4 ![]()
Soule S, King JA, Millar RP.
Incorporation of D-Ala2 in growth hormone-releasing hormone-(1–29)-NH2 increases the half-life and decreases metabolic clearance in normal men.
Journal of Clinical Endocrinology & Metabolism. 1994;79(4):1208–1211.
PMID: 7962295 ![]()
DOI: 10.1210/jcem.79.4.7962295 ![]()
Memdouh S, Gavrilović I, Ng K, Cowan D, Abbate V.
Advances in the detection of growth hormone releasing hormone synthetic analogs.
Drug Testing and Analysis. 2021;13(11–12):1871–1887.
PMID: 34665524 ![]()
DOI: 10.1002/dta.3183 ![]()
Product Name: CJC-1295 No DAC
Product Type: Synthetic Modified GHRH(1–29) Analogue
Amount: 5 mg / 10 mg
Form: Lyophilized Powder
Purity: ≥99%
Storage: 2–8°C
Batch Testing: Batch-Specific COA Available
Intended Use: Research Use Only
This product is supplied strictly for laboratory research purposes.
It is not intended for human use, veterinary use, diagnostic applications, or therapeutic and clinical applications.
True Peptides does not provide dosing guidance, administration instructions, or usage recommendations.
Product Name: 10-Amino-1MQ 50 mg
LOT Number: 240710A
Expiration Date: July 18, 2028
Storage Conditions: 2–8 °C, unless otherwise specified
Use Category: Research Use Only
This batch is linked to analytical documentation intended to support traceability and laboratory recordkeeping.
The COA may include:
• batch identification
• analytical purity results
• identity verification
• method reference information
This page applies only to the lot number listed above.
Documentation shown here is batch-specific and should not be used as a reference for other lots or product versions.
This material is supplied strictly for laboratory research purposes.
It is not intended for:
• human use
• veterinary use
• diagnostic applications
• therapeutic or clinical applications
True Peptides does not provide dosing guidance, administration instructions, or usage recommendations.
All analytical data provided is batch-specific and linked to the corresponding product.
Transparency in documentation allows for:
True Peptides prioritizes accessible and verifiable documentation as a core part of its quality framework.
Peptide materials are supplied as lyophilized powders.
Recommended storage: 2–8°C refrigerated, unless otherwise specified.
Proper storage conditions are required to maintain material integrity. Stability may vary depending on peptide structure and environmental exposure.
Handling should be performed within controlled laboratory conditions.